Hindustan Bio Sciences's revenue for the
three
months ended in Dec. 2023 was ₹3.22 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹9.19 Mil.
Hindustan Bio Sciences's Revenue per Share for the
three
months ended in Dec. 2023 was ₹0.33.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.91.
Warning Sign:
Hindustan Bio Sciences Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Hindustan Bio Sciences was 185.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -23.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -20.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -9.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Hindustan Bio Sciences's highest 3-Year average Revenue per Share Growth Rate was 41.20% per year. The lowest was -51.00% per year. And the median was -13.65% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Hindustan Bio Sciences's Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hindustan Bio Sciences's Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's Revenue distribution charts can be found below:
* The bar in red indicates where Hindustan Bio Sciences's Revenue falls into.
Hindustan Bio Sciences Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹9.19 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hindustan Bio Sciences (BOM:532041) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Hindustan Bio Sciences Revenue Related Terms
Thank you for viewing the detailed overview of Hindustan Bio Sciences's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Hindustan Bio Sciences (BOM:532041) Business Description
Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:532041 has been successfully added to your 